Back to all news

FierceBiotech’s 2016 “Fierce 15”

Faber lawyers and contract specialists are working with 3 of the dynamic companies on this year’s list – and over 1/3 of the companies listed in the past three years or their scientific founders.

On September 19, 2016, FierceBiotech released their eagerly-anticipated annual “Fierce 15” list – “The FierceBiotech Fierce 15 is a hunt for the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven't been done before. Fifteen privately held drug developers or platform biotechs with the potential to have a huge impact on the treatment of human diseases. The Fierce 15 celebrates the spirit of being "fierce"--championing innovation and creativity, even in the face of intense competition--and has recognized a number of distinguished biotechs over the years.”

The firm acts as transactional counsel to 3 of these dynamic companies: Neon Therapeutics, Oncorus and Rhythm Pharmaceuticals.  And, for the 45 companies listed in the past three years, the firms acts as transactional counsel, or as counsel to the primary scientific founders or lead investors, to 16 of these companies.

Related News Stories

No items found.